BPF treatment indeed inhibited the CLP-induced production of IL-6, TNF-α, and CXCL1 by sepsis-induced peritoneal macrophages (Figure 6A–C) (consistent with the results in HUVECs and THP-1-macrophages). The gene discussed is CXCL1; the disease is Sepsis.